Yu Zhong
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- RNA and protein synthesis mechanisms
- Extracellular vesicles in disease
Papers in
-
- RNA modifications and cancer 6
- RNA Research and Splicing 2
- Plant Gene Expression Analysis 2
- RNA and protein synthesis mechanisms 2
-
- Cancer-related molecular mechanisms research 8
- Co-authors
- Xiaoling Li (2 shared papers)Wei Xiong (2 shared papers)Can Guo (2 shared papers)Fang Xiong (2 shared papers)Guiyuan Li (2 shared papers)Yong Li (2 shared papers)Zhaoyang Zeng (2 shared papers)Xu Wu (1 shared paper)
- Journals
- Frontiers in Oncology (2 papers)International Journal of Biological Macromolecules (1 paper)Human Cell (1 paper)Medicine (1 paper)Future Oncology (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Yu Zhong
23 papers receiving 608 citations
Yu Zhong's Hit Papers
Peers
Comparison fields: 5 of 73
- Cancer Research 411
- Molecular Biology 476
- Ophthalmology 19
- Immunology 39
- Radiology, Nuclear Medicine and Imaging 38
Countries citing papers authored by Yu Zhong
This map shows the geographic impact of Yu Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Zhong more than expected).
Fields of papers citing papers by Yu Zhong
This network shows the impact of papers produced by Yu Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Zhong. The network helps show where Yu Zhong may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu Zhong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA Hit paper breakdown → | 2020 | 412 |
| 2 | 2021 | 60 | |
| 3 | 2016 | 25 | |
| 4 | 2022 | 17 | |
| 5 | 2021 | 16 | |
| 6 | 2023 | 14 | |
| 7 | 2021 | 12 | |
| 8 | 2022 | 10 | |
| 9 | 2022 | 8 | |
| 10 | 2022 | 7 | |
| 11 | 2022 | 5 | |
| 12 | 2023 | 4 | |
| 13 | Intrarenal angiotensin II plays an important role in renal fibrosis in primary IgA nephropathy. | 2016 | 3 |
| 14 | 2024 | 3 | |
| 15 | 2022 | 3 | |
| 16 | 2024 | 3 | |
| 17 | 2023 | 2 | |
| 18 | 2025 | 2 | |
| 19 | 2022 | 2 | |
| 20 | [Killing effect improved by fusion gene HRE1.Egr-1. yCDglyTK on gene-radio therapy of nasopharyngeal cancer in vitro]. | 2008 | 2 |
About Yu Zhong
Yu Zhong is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 24 papers that have together received 614 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (6 papers), Ferroptosis and cancer prognosis (3 papers), CAR-T cell therapy research (2 papers), RNA Research and Splicing (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Plant Gene Expression Analysis (2 papers) and RNA and protein synthesis mechanisms (2 papers). The work is most often cited by research in Cancer Research (411 citations), Molecular Biology (476 citations), Ophthalmology (19 citations), Immunology (39 citations) and Radiology, Nuclear Medicine and Imaging (38 citations). Yu Zhong has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xiaoling Li, Wei Xiong, Can Guo, Fang Xiong, Guiyuan Li, Yong Li, Zhaoyang Zeng, Xu Wu, Peng Miao and Xiangying Deng. Their work appears in journals such as Frontiers in Oncology, International Journal of Biological Macromolecules, Human Cell, Medicine and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.